Results 271 to 280 of about 322,217 (303)
Some of the next articles are maybe not open access.
Circulating Tumor Cells and Circulating Tumor DNA in Urologic Cancers
Urologic Clinics of North America, 2023Liquid biopsies such as circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA) have great potential to serve as prognostic and predictive biomarkers in urologic cancers. The possibility of using liquid biopsies for real-time noninvasive and dynamic monitoring of response to therapy has been an active area of investigation.
Ikenna, Madueke +2 more
openaire +2 more sources
Tumor heterogeneity and circulating tumor cells
Cancer Letters, 2016In patients with cancer, individualized treatment strategies are generally guided by an analysis of molecular biomarkers. However, genetic instability allows tumor cells to lose monoclonality and acquire genetic heterogeneity, an important characteristic of tumors, during disease progression.
Chufeng Zhang +4 more
openaire +2 more sources
2010
Circulating tumor cells (CTCs) can be separated and characterized from normal hematopoietic cellular constituents by a variety of methods. Different strategies have included separation by physical characteristics, such as size or weight, or by biological characteristics, such as expression of epithelial or cancer-specific markers.
Daniel F, Hayes, Jeffrey B, Smerage
openaire +2 more sources
Circulating tumor cells (CTCs) can be separated and characterized from normal hematopoietic cellular constituents by a variety of methods. Different strategies have included separation by physical characteristics, such as size or weight, or by biological characteristics, such as expression of epithelial or cancer-specific markers.
Daniel F, Hayes, Jeffrey B, Smerage
openaire +2 more sources
Circulating Tumor Cells Revisited
JAMA, 2010DESPITE THE USE OF MODERN HIGH-RESOLUTION imaging technologies, it is not possible to detect tumor cell metastasis at a single cell level. To date, cancer treatment is initiated only after the clinical presentation of disease. This approach generally is unsuccessful and translates into the dogma that metastasis is a terminal process, generally viewed ...
Massimo, Cristofanilli, Stephan, Braun
openaire +2 more sources
Molecular Diagnosis & Therapy, 2012
Circulating tumor cells (CTCs) are cells of presumed epithelial origin, whose prognostic and predictive value in metastatic cancer patients has recently been demonstrated. To date, the count of CTCs through the CellSearch® system represents a valid approach for monitoring disease status in patients with metastatic colorectal, breast, and prostate ...
GAZZANIGA, PAOLA +5 more
openaire +3 more sources
Circulating tumor cells (CTCs) are cells of presumed epithelial origin, whose prognostic and predictive value in metastatic cancer patients has recently been demonstrated. To date, the count of CTCs through the CellSearch® system represents a valid approach for monitoring disease status in patients with metastatic colorectal, breast, and prostate ...
GAZZANIGA, PAOLA +5 more
openaire +3 more sources
Circulating tumor cells in breast cancer
Current Opinion in Obstetrics & Gynecology, 2008To critically review the latest findings concerning the detection and characterization of circulating tumor cells in breast cancer.Various studies have used different methods and markers for circulating tumor cell detection in breast cancer. Data on the prognostic value of circulating tumor cell monitoring by the CellSearch system are now available in ...
Ignatiadis, Michail +2 more
openaire +3 more sources
Circulating tumor cells: the Grand Challenge
Lab on a Chip, 2011Jaap den Toonder, Lab on a Chip Editorial Board Member, discusses how the field of circulating tumour cells defines one of the Grand Challenges for the microfluidics community.
openaire +2 more sources
Circulating tumor DNA in advanced solid tumors: Clinical relevance and future directions
Ca-A Cancer Journal for Clinicians, 2021Heather A Parsons +2 more
exaly